Pfizer Licenses Selzentry to Non-Profit for HIV Prevention
In this other article, it is stated that: "(Pfizer) has agreed to give IPM a royalty-free license to maraviroc, its newly-approved HIV treatment, as a microbicide for the prevention of HIV infection."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.